Key result
Phenome-wide Mendelian randomization identifies 44 putatively causal traits for early AMD.
Why the study?
Age-related macular degeneration is a leading cause of blindness with limited understanding of causal factors and therapeutic targets.
Observational (n=105,248)
Mendelian randomization
Yes
Odds Ratio: 1.07
p-value: p=6.80E-06
A phenome-wide Mendelian randomisation analysis identified several lipid, complement, immune cell, and serum protein traits as putatively causal factors for age-related macular degeneration, highlighting potential therapeutic targets.
Supports investigation of lipid, complement, and immune pathways in early AMD; hypothesis-generating and requires interventional validation before clinical translation.
Background Age-related macular degeneration (AMD) is a leading cause of blindness in the industrialised world and is projected to affect >280 million people worldwide by 2040. Aiming to identify causal factors and potential therapeutic targets for this common condition, we designed and undertook a phenome-wide Mendelian randomisation (MR) study. Methods We evaluated the effect of 4,591 exposure traits on early AMD using univariable MR. Statistically significant results were explored further using: validation in an advanced AMD cohort; MR Bayesian model averaging (MR-BMA); and multivariable MR. Results Overall, 44 traits were found to be putatively causal for early AMD in univariable analysis. Serum proteins that were found to have significant relationships with AMD included S100-A5 (odds ratio [OR]=1.07, p-value=6.80E-06), cathepsin F (OR=1.10, p-value=7.16E-05) and serine palmitoyltransferase 2 (OR=0.86, p-value=1.00E-03). Univariable MR analysis also supported roles for complement and immune cell traits. Although numerous lipid traits were found to be significantly related to AMD, MR-BMA suggested a driving causal role for serum sphingomyelin (marginal inclusion probability [MIP]=0.76; model-averaged causal effect [MACE]=0.29). Conclusions The results of this MR study support several putative causal factors for AMD and highlight avenues for future translational research. Funding This project was funded by the Wellcome Trust (224643/Z/21/Z); the University of Manchester’s Wellcome Institutional Strategic Support Fund (Wellcome ISSF) grant (204796/Z/16/Z); the UK National Institute for Health Research (NIHR) Academic Clinical Fellow and Clinical Lecturer Programmes; Retina UK and Fight for Sight (GR586); the Australian National Health and Medical Research Council (NHMRC) (1150144). IMPACT STATEMENT A phenome-wide Mendelian randomisation analysis revealed a causal link between age-related macular degeneration and a number of lipid, complement, immune cell, and serum protein traits, highlighting potential treatment targets.
No takes yet. Share an insight, caveat, or question.
Julian et al. (2022) conducted an observational in Age-related macular degeneration (AMD) (n=105,248). Serum proteins and lipid traits (e.g., S100-A5, cathepsin F, serine palmitoyltransferase 2, sphingomyelin) vs. Unexposed / genetic reference was evaluated on Early age-related macular degeneration (OR 1.07, p=6.80E-06). Phenome-wide Mendelian randomization identified 44 putatively causal traits for early AMD, including serum S100-A5 (OR 1.07), cathepsin F (OR 1.10), and serine palmitoyltransferase 2 (OR 0.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: